CD8^+^ T cells play critical roles in the immune response to pathogens and vaccine efficacy depends on strong long-term development of immune memory in both the B cell and T cell compartment. Memory CD8^+^ T cells develop following antigenic stimulation over several identifiable phases. Initial antigen recognition initiates clonal expansion of naïve T cells, which develop into effector T cells. Upon antigen clearance, these effector T cells undergo a contraction phase, and the development of memory precursor effector cells leading to memory T cells. Using mouse models and model pathogens such as *Lymphocytic Choriomeningitis Virus* (*LCMV*) and *Listeria monocytogenes (L. monocytogenes*), these phases have been identified based on expression of surface markers and transcription factors (for review see ref. [@b1]). The development of memory T cells requires signals from the cytokines IL-15 and IL-7 and expression of the common receptor chain for both cytokines IL-7Rα (CD127)[@b1], and responding naïve CD8^+^ T cells develop into Short-Lived Effector Cells (SLECs) carrying the phenotype CD127^lo^/KLRG1^hi^. Once the pathogen is cleared, some effector cells become Memory Precursor Effector Cells (MPECs) and take on the phenotype CD127^hi^/KLRG1^lo^. SLECs express higher levels of transcription factor T-bet and lower levels of Eomesodermin (Eomes) (higher T-bet:Eomes ratio), while MPECs exhibit the reverse behavior, expressing higher levels of Eomes and lower levels of T-bet. Thus KLRG1^hi^/T-bet^hi^ cells are generally SLECs while KLRG1^lo^/Eomes^hi^ are generally destined to become long-term memory cells[@b1].

The parameters for optimal development of the CD8^+^ T cell immune response have been of keen interest. The strength of the signal that T cells receive via the TcR is one important factor in generation of effector and memory cells. Antigen dose has been used as a proxy for TcR signal strength, and has been shown to be inversely correlated with CD127 expression[@b2]. It has also been suggested that short or weak TcR stimuli results in unfit cells that do not survive *in vivo*[@b3]. Bevan and colleagues have also reported that CD8^+^ T cells that receive short and weak stimuli generate fewer memory T cells, although the resultant populations have the same functional capacity as T cells that received strong signals[@b4][@b5]. These data suggest a direct correlation between TcR signal strength and T cell response for generation of memory. The tyrosine kinase Itk acts downstream of the TcR to regulate TcR signal strength[@b6]. As a result, Itk deficiency in mice and humans affects the development and function of CD4^+^, CD8^+^ T cells, *i*NKT cells and γδ T cells[@b7][@b8][@b9][@b10][@b11][@b12][@b13][@b14][@b15][@b16]. In addition, Itk^−/−^ CD4^+^ T cells exhibit reduced Th2 responses, and reduced IL-17A production in Th17 cells[@b17][@b18][@b19]. Furthermore, Itk^−/−^ mice have a population of innate memory CD8^+^ T cells due to CD8^+^ T cell extrinsic dysregulated production of IL-4[@b20][@b21]. Thus Itk^−/−^ mice have complex phenotypes that affect both CD4^+^ and CD8^+^ T cells[@b22].

Given the critical role that Itk plays in TcR signals, its role in CD8^+^ T cell responses in infection is of considerable interest and has been examined using mice lacking this kinase. The data suggested that Itk plays a role in CD8^+^ T cell antiviral responses, with decreased CD8^+^ T cell cytotoxic function against *LCMV*, *Vaccinia Virus* (*VV*), and *Vesicular Stomatitis Virus* (*VSV*). In addition, while viral clearance of *VV* infection was observed in the absence of Itk, the kinetics was delayed[@b23]. However, this work was performed prior to the discovery of the innate memory phenotype CD8^+^ T cells in the Itk^−/−^ mice[@b14][@b15][@b24], prompting re-evaluation of these conclusions about the role of Itk in CD8^+^ T cell response to infection. We have previously examined the function of the CD8^+^ innate memory phenotype in mice during the early response to infection with *L. monocytogenes* and found that Itk^−/−^ mice were able to clear infections with *L. monocytogenes* more quickly than WT mice. However, this was not antigen specific and primarily due to the elevated numbers of IMP CD8^+^ T cells that develop in the absence of Itk[@b24]. It is therefore very likely that previous studies using Itk^−/−^ mice to examine CD8^+^ T cell response to infection were affected by the presence of these populations of IMP cells, particularly since it has been shown that preexisting memory cells affect subsequent responses of naïve CD8^+^ T cells[@b25]. Thus the role of Itk in CD8^+^ antigen specific T cell response to infection as developed from naïve precursors, or in the development of CD8^+^ T cell memory is unclear. We have therefore reexamined the role of Itk in the activation and differentiation of naïve Itk^−/−^ CD8^+^ T cells using naive Ovalbumin specific OTI T-cells (on a RAG deficient background), to infection with *L. monocytogenes* carrying Ovalbumin (*LM-OVA*).

Results
=======

The absence of other T cell populations allows the development of naïve Itk^−/−^ CD8^+^ T cells
-----------------------------------------------------------------------------------------------

The ability to specifically examine the role of Itk in the generation of antigen specific CD8^+^ T cell responses and development of memory is hampered by the presence of altered populations of CD8^+^ (and CD4^+^) T cells in mice lacking Itk. To bypass these caveats with using Itk^−/−^ mice, we generated Ovalbumin peptide (SIINFEKL) specific OTI transgenic T cell receptor mice on a Rag^−/−^ background also lacking Itk (Itk^−/−^ OTI/Rag^−/−^). We found that \>95% of the CD8^+^ T cell population from such mice had a naïve phenotype (CD44^lo^/CD62L^hi^/CD122^lo^) (data not shown), and thus used naïve T cells from these mice to study the response of antigen specific naïve CD8^+^ T cells in response to infection.

Itk regulates the quality of the antigen-specific CD8^+^ T cell cytokine response *in vitro* in a digital-like manner
---------------------------------------------------------------------------------------------------------------------

Isolated naïve WT and Itk^−/−^ T cells were co-cultured in vitro with SIINFEKL peptide-pulsed dendritic cells (DCs) at varying concentrations. After 5 days, the cells were restimulated using the same initial concentration of peptide and then analyzed for expression of cytokines and transcription factors as a measure of their response. Given the role of Itk in regulating TcR signals, we were surprised to find that Itk^−/−^ T cells proliferated similarly to, or better than WT T cells as measured by cell numbers and expression of proliferative marker Ki67 ([Fig. 1A](#f1){ref-type="fig"}). However, a higher frequency of WT T cells produced IFN-γ and TNFα, as well as amount of cytokine/cell as measured by the MFI, although for TNFα, this was less pronounced ([Fig. 1B, D](#f1){ref-type="fig"}). The observed difference in proportion of responding cells was more pronounced in those T cells producing IFN-γ, and in those higher quality T cells that produced both IFN-γ and TNFα (double producers). Note that there was no difference in the capacity of Itk^−/−^ T cells in producing these cytokines when they were stimulated using PMA/Ionomycin to bypass the TcR ([Fig. 1C](#f1){ref-type="fig"}). Furthermore, while it is possible that differences in cell viability could be responsible for the differences in cytokine production, we think this is less likely since there was no difference in cell numbers between WT and Itk^−/−^ T cells.

This suggests that Itk does not regulate proliferative capacity in response to antigen, but regulates the ability of responding CD8^+^ T cells to produce IFN-γ and TNFα upon TcR restimulation. We also noted that the absence of Itk did not affect the EC~50~ for peptide activation, but affected the maximum achievable at specific concentrations, suggesting a digital-type response. WT and Itk^−/−^ T cells expressed T-bet and Eomes, particularly at higher doses, and both populations had elevated frequency of Eomes single positive cells at low dose of peptide, but higher frequency of T-bet and T-bet/Eomes double positive cells at the higher doses ([Fig. 1E](#f1){ref-type="fig"}).

Itk suppresses the development of CD8^+^ T cell memory during *L. monocytogenes* infection
------------------------------------------------------------------------------------------

We next examined Itk\'s role in the CD8^+^ T cell response *in vivo* during infection with *L. monocytogenes* carrying the model antigen Ovalbumin (*LM-OVA*). We transferred naïve WT or Itk^−/−^ T cells into CD45.1 congenic WT mice, followed by infection with 5 × 10^5^ *LM-OVA* within 24 hours after adoptive transfer. Blood (and spleens) from infected mice were analyzed over time to monitor the response of the transferred T cells. Infection with *LM-OVA* resulted in similar expansion of WT and Itk^−/−^ T cells 7--12 post infection, but while WT T cells underwent rapid contraction to a low number by day 21, a significantly higher number of Itk^−/−^ T cells remained at 21 and 30 days post infection ([Fig. 2A](#f2){ref-type="fig"}), indicating that Itk signals suppress the conversion of effector CD8^+^ T cells to long-term memory cells during this infection. There was no difference in bacterial clearance between recipient mice, which was cleared by day 7 post-infection ([Fig. 2B](#f2){ref-type="fig"}). These data suggest that Itk signals play a negative role in the response of CD8^+^ T cells during infection with *L. monocytogenes*.

Itk signals negatively regulate the development of MPEC during infection
------------------------------------------------------------------------

We followed the differentiation of transferred naïve WT and Itk^−/−^ T cells to SLECs and MPECs by examining their expression of CD127 and KLRG1 during infection with *LM-OVA*. We found a significantly higher frequency of KLRG1^lo^/CD127^hi^ MPECs among the Itk^−/−^ T cells, starting at the earliest time point we examined, day 7 ([Fig. 2C](#f2){ref-type="fig"}). This higher frequency of MPEC generation was not observed at later time points as the WT cells caught up. By contrast, there was no difference in the frequency of SLECs ([Fig. 2C](#f2){ref-type="fig"}). Thus the absence of Itk signals results in enhanced generation/survival of KLRG1^lo^ CD127^hi^ MPECs during infection, and suggests that signals regulating the development of MPEC are inhibited by Itk signaling.

Itk signals negatively regulate CD127 and Eomesodermin expression during infection
----------------------------------------------------------------------------------

The development of MPECs is controlled in part by the expression of Eomes, and we found that a higher frequency of Itk^−/−^ T cells expressed Eomes compared to WT T cells 7--21 days post *LM-OVA* infection. By contrast, there was little difference in the frequency of T-bet expressing cells ([Fig. 2D](#f2){ref-type="fig"}). Indeed, we found that a higher frequency of Itk^−/−^ T cells expressed higher levels of Eomes and its target CD127 at day 7, and the WT T cells do not catch up until day 21. Thus Itk signals suppress early expression of Eomes and CD127 ([Fig. 2E](#f2){ref-type="fig"}). Berg et al recently suggested that Itk regulates the expression of IRF4, which is a negative regulator of Eomes[@b26]. However, we did not see any differences in induction of IRF4 when naïve Itk^−/−^ T cells are activated by antigen *in vitro* or *in vivo*, suggesting that mature peripheral T cells may have different requirements for induction of IRF4 via the TcR ([Fig. 2F, G](#f2){ref-type="fig"}). These data suggest one explanation for the more efficient conversion of Itk^−/−^ T cells to MPEC during infection, earlier and enhanced expression of Eomes, potentially leading to enhanced development of MPECs.

Itk intrinsically promotes cytokine production during the CD8^+^ T cell response *in vivo* in a digital manner
--------------------------------------------------------------------------------------------------------------

We next examined effector cytokine responses of transferred T cells after *LM-OVA* infection. We found that both WT and Itk^−/−^ T cells responded to infection with cytokine production upon restimulation with the SIINFEKL peptide in vitro (as measured by percent responding cells and MFI of IFN-γ and TNFα expression). A smaller proportion of Itk^−/−^ T cells produced cytokine (both IFN-γ and TNFα and double producers) ([Fig. 3A, B](#f3){ref-type="fig"}), however, the cells that produced cytokine produced the same amount as WT cells (MFI, [Fig. 3A](#f3){ref-type="fig"}). These results suggest that Itk signaling is critical for determining whether responding cells will produce cytokine, but not how much cytokine they produce, akin to a digital response.

Itk is not required for antigen specific recall response following infection
----------------------------------------------------------------------------

Since the absence of Itk enhanced the development of MPEC during infection, we asked whether the resultant memory cells exhibited differential response to reinfection. In contrast to the effector cytokine response during the primary T cell response, there was no difference in effector cytokine production, including frequency or amount/cell ([Fig. 4A](#f4){ref-type="fig"}). Note that the number of cells upon reinfection was lower in the WT mice, in agreement with the lower number of WT MPECs generated ([Fig. 4B](#f4){ref-type="fig"}, see [Fig. 2](#f2){ref-type="fig"}), however, there was no difference in fold expansion between Itk^−/−^ and WT cells (ratio Itk^−/−^:WT cell numbers), indicating that reinfection induced similar expansion of memory cells that developed ([Fig. 4B](#f4){ref-type="fig"}). Indeed, transfer of equal numbers of WT and Itk^−/−^ memory CD8^+^ T cells into naïve recipients, followed by similar infection with *LM-OVA* also resulted in statistically similar expansion between the WT and Itk^−/−^ memory CD8^+^ T cells, although it is possible that the inclusion of more mice in this experiment would reveal a significant difference ([Fig. 4C](#f4){ref-type="fig"}). Thus, while Itk signals are important in enhancing the frequency of cytokine producing cells within the responding population during a primary T cell response, as well as in delaying the timing of the development of MPECS, these signals are not important for the recall response of the fully differentiated memory population.

Discussion
==========

Early antigen stimulation of CD8^+^ T cells via the TcR has been proposed to be an important parameter in regulating the nature of the response, as well as generation of memory. This early TcR signal can be regulated by antigen dose, antigen affinity (for TcR) or intracellular signaling controlling TcR signal strength. TcR signal strength, antigen dose, and antigen affinity have sometimes been used interchangeable, however, they are different parameters. For example, antigen affinity seems to act in an analog manner, altering the EC~50~ of peptide required for functional activation as illustrated by Bevan and colleagues[@b5]. In that case antigen affinity does not affect whether a CD8^+^ T cell response is generated, and effector function is not affected. However, there is reduced proliferation and the timing of the T cell contraction is shifted earlier with low affinity antigen. The expression of CD8 can also control the response of CD8^+^ T cells in an analog-like fashion, with differences in CD8 altering the EC~50~ of peptide required for functional activation *in vitro*[@b27]. By contrast, changes in the expression of the protein tyrosine phosphatase SHP-1, which regulates TcR signal strength[@b28], does not affect the EC~50~ for antigen, but affects the magnitude of the response at the same antigen concentrations *in vitro* (digital-like)[@b27]. *In vivo* SHP-1 regulates the magnitude of the peak of the CD8^+^ T cell response, along with the frequency of SLECs generated, without affecting the effector cytokine or MPECs generated[@b29]. Our results indicate that as a regulator of TcR signaling in the vein of SHP-1, Itk acts in digital-like manner for the cytokine response, with little effect on the effectiveness of antigen activation (EC~50~), but on the likelihood that responding cells will produce cytokine. Our results also suggest that Itk acts in a "tuning" capacity in regulating the ability of cells to differentiate to MPECs, and thus generate memory cells.

Stimulating CD8^+^ T cells carrying a TcRβ chain that reduces signaling results in reduced development of memory, without affecting development of effector responses[@b30], and reducing the affinity of the TcR ligands can rescue the development of memory in these cells[@b31]. This rescue of memory development in these T cells is suggested to be due to NFκB signaling[@b31]. These data suggests that reduced TcR signaling leads to reduced development of effector and memory cells. Our data with Itk deficient T cells, which also exhibit reduced TcR signaling, provides a different view, in that we observe normal effector cell development, but enhanced memory development. Of course, while CD8^+^ T cells carrying the altered TcRβ chain do exhibit reduced TcR signaling, they may also have other signaling pathways that are altered, that may affect effector and memory cell development, particularly since memory development in these cells can be rescued by using a lower affinity ligand[@b30][@b31]. The groups of Jordan as well as of Teixeiro have previously shown that weak TCR signaling favors the generation of memory CD8 T cells[@b31][@b32]. Indeed, the work of Smith-Garvin et al use, among others, a SLP-76 Y145F mutant which regulates its interaction with Itk, and our work with Itk leads to similar conclusions regarding the role of this pathway on regulating the development of memory CD8^+^ T cells. Thus our data are in support of the idea that weak TCR signals preferentially allow the development of CD8^+^ memory T cells.

We found that Itk^−/−^ T cells exhibit early expression of Eomes, and the mechanism is of considerable interest. Berg et al recently suggested that Itk regulates the expression of IRF4, which is a negative regulator of Eomes[@b26]. However, these experiments were performed using Itk^−/−^ thymocytes, which, as discussed earlier, may have developmental differences compared to WT T cells. In our experiments we have not seen any differences in induction of IRF4 when naïve Itk^−/−^ OTI/Rag^−/−^ T cells are activated by antigen *in vitro* or *in vivo*, suggesting that mature peripheral T cells may have different requirements for induction of IRF4 via the TcR. Of significant interest is the recent report that Eomes is regulated by the small GTPase, N-Ras, and that the absence of N-Ras in naïve T cell results in reduced development of MPECs[@b33]. As Itk deficient T cells exhibit the inverse phenotype, this would suggest that Itk negatively regulates N-Ras activity, and in its absence, there is elevated expression of Eomes. As previous studies have shown, Itk regulates the activation of the Ras/MAPK pathway downstream of the TcR[@b34], although this regulation may be more complex. This differential regulation of Eomes may endow Itk^−/−^ T cells with the ability to generate early MPECs.

During the immune response, an increase in SLEC has been suggested to reduce the availability of precursors able to become MPECs[@b35]. This increase in SLEC is suggested to reduce the availability of precursors able to become MPECs. Our data suggest that these may be separable events, and that enhanced early MPEC development can occur in the face of apparently normal SLEC development. While it can be difficult to untangle the effects of differences in bacterial clearance, and the corresponding effects on inflammation, we note that there is no difference in bacterial clearance between WT and Itk^−/−^ T cell recipients, suggesting that this is not likely to be a factor in the differential development of MPECs. Our work therefore supports a model where weaker TCR signals due to lack of Itk in CD8^+^ T cells contributes to the promotion of earlier MPEC development.

The findings reported in this work, along with our recently reported findings on the development of innate memory phenotype T cells (or IMP cells), suggest a general model for the ability of TcR signals to tune cytokine-mediated signals. We have recently shown that development of IMP CD8^+^ T cells driven by IL-4 signals is tuned by TcR signals traveling via Itk, such that the absence of Itk enhances the ability of IL-4 to drive development of IMP CD8^+^ T cells[@b21]. We suggest that similar to the development of IMP CD8^+^ T cells driven by IL-4, development of MPECs driven by cytokines regulating this process may be tuned by TCR signals traveling via Itk.

In contrast to developing Itk^−/−^ effector T cells, Itk^−/−^ CD8^+^ memory T cells were able to respond equivalent to WT cells in both frequency and cytokine expression upon bacterial rechallenge. This supports previous work showing that TcR signaling is different between naive and memory T cells (see review[@b36]), such that there may be less of a dependence on Itk signals for cytokine expression. Based on these findings, there is a strong potential for the use of Itk inhibitors in manipulating the CD8^+^ T cell response to enhance early development of memory without compromising memory recall responses. TcR signal strength has been proposed as a parameter that determines the CD8^+^ T cell response, including memory development[@b1]. We have referred here to the behavior of Itk in regulating these pathways as acting in a digital manner (in regulating cytokine production), and as a tuner (in regulating memory cell development). We refer to the digital response with regards to the cytokine response, in that while the percent of cells that produce cytokine *in vitro* and *in vivo* is different between WT and Itk^−/−^ T cells, the amount of cytokine that they make (as read out by MFI) is not different. This suggests that Itk signals control whether the cells will respond (digital), but not the amount of cytokine that the responding cells make (which we propose would be an analog response). We refer to Itk as a tuner in regulating memory cell development since the absence of Itk enhances memory cell development in a seeming analog manner, not whether they will develop into memory cells, suggesting an analog like behavior controllable by a tuner. Thus we have uncovered a tuning role for Itk in regulating TcR signal strength leading to expression of Eomes during the primary response, and to control of the development of memory precursor cells. While our experiments have only examined this idea in a model of bacterial infection, our findings suggest that manipulating early TcR signals by manipulating Itk activity will have a significant impact on subsequent development of memory cells during infections with other pathogens.

Methods
=======

Mice
----

All mice used are in C57BL6 background. Itk^−/−^ OTI/Rag^−/−^ mice were generated by crossing OTI/Rag1^−/−^ (Taconic) and Itk^−/−^ mice. CD45.1 mice or Thy1a (Jackson Laboratory) mice were used as recipients in the adoptive transfer experiments. All experiments were reviewed and approved by the Cornell University Institutional Animal Care and Use committee (IACUC), carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals issued by the National Institutes of Health.

Adoptive cell transfers and *Listeria monocytogenes* infection
--------------------------------------------------------------

10^5^ T cells/mouse (WT or Itk^−/−^ OTI/Rag^−/−^ T cells) were transferred via retro-orbital injection. This results in an \~10% take so that 10^4^ cells/mouse are available for immune response[@b5]. This was followed by IP infection with 5 × 10^5^ CFU/mouse *Listeria monocytogenes* carrying the model antigen Ovalbumin on the ActA- mutant background (*LM-OVA*, a gift from Dr. Hao Shen, University of Pennsylvania) within 24 h of T cell transfer. For reinfection studies mice were infected with 5 × 10^6^ CFU/mouse via IP injection. At the indicated time after *LM-OVA* infection, mice were sacrificed and blood, spleen, and lymph nodes were harvested. For memory T cell expansion studies, purified naïve CD45.1 WT or Itk^−/−^ T cells were transferred into CD45.1 congenic WT mice. Recipient mice were then infected with *LM-OVA* (5 × 10^6^ CFU/mouse) as previously described. After 30 days, memory donor CD45.2 CD8^+^ T cells were isolated by FACS, then transferred (40,000/mouse) into naïve mice, which were infected with 10× the initial dose of bacteria, and number of donor CD45.2 CD8^+^ T cells analyzed 3 days post-infection.

Cell isolation and purification
-------------------------------

Naïve T cells were purified from spleen or lymph nodes of WT and Itk^−/−^ OTI/Rag^−/−^ mice by negative selection using: biotin-anti-Fc block, biotin-anti-F4/80, biotin-anti-CD11c, biotin-anti-CD11b, biotin-anti-CD49b, biotin-anti-DX5, biotin-anti-Ter119, biotin-anti-Gr-1, and biotin-anti-CD25 (eBiosciences Inc). Negative selection of purified naïve T cells was done by anti-biotin beads and MACS columns, and verified by FACS.

Cell culture and stimulation conditions
---------------------------------------

Complete RPMI (Invitrogen Inc) with 10% FBS was used for cell culture. Purified naïve T cells were cultured at a concentration of 10^6^/ml with mitomycin C-treated splenocytes (as APCs) from Rag^−/−^ mice (ratio 1:5). OVA~257--264~ peptide (SIINFEKL, Peptides International Inc.) at the indicated concentrations (10^−8^ μM to 1 μM) was used and cells cultured for five days. On the 5^th^ day, cells were restimulated with SIINFEKL peptide at the same concentration used for the original culture, or PMA (20 ng/ml)/Ionomycin (2 μM) (P/I) for 4--6 hours in the presence of Brefeldin A (BFA, 100 μg/ml, Sigma Aldrich, Inc). For cells from *LM-OVA* infection, cells were stimulated with 1 μM SIINFEKL peptide or P/I in the presence of BFA for 4--6 hours.

FACS analysis
-------------

Blood samples were collected in 50 U/ml heparin (Sigma Aldrich, Inc.), and ACK (Ammonium-Chloride-Potassium) lysis buffer before FACS analysis. The following antibodies were used: FITC-anti-KLRG1, APC-anti-CD45.1, PECy7-anti-CD127, Pacific Blue-anti-CD122, PerCP-Cy 5.5-anti-EOMES, PECy7-anti-IFN-γ (eBiosciences Inc.), PE-anti-CD62L, PE-anti-Thy1a, APC-Cy7-anti-CD45.2, Alexa-Fluor-700-anti-CD62L, Horizon-V500-anti-CD44, PE-anti-TNFα, APC-anti-T-bet, PE-CF594-CD8α, ACP-Cy7-TCRVα2 and AlexaFluor700-anti-Ki67 (BD Biosciences, Inc.), ECD-Texas Red-anti-CD8α (Invitrogen, Inc.), Fc Block, FITC-CD45.2, and AF700-CD45.2 (Biolegend). MFI was determined by gating on cytokine positive populations. All transferred cells analyzed were gated by CD8^+^ and CD45.2^+^, CD45.1^+^ or Thy1.2^+^ markers.

Statistical analysis
--------------------

Data are presented as a representative experiment and 3--5 mice per group were used for each experiment. Student\'s *t* test and ANOVA were performed using *Prism* to evaluate statistical significance with *p* \< 0.05 considered statistically significant.
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![Itk regulates the quality of the antigen-specific CD8^+^ T cell response in vitro.\
Naïve WT or Itk^−/−^ T cells were stimulated with the indicated concentration of SEINFEKL peptide for 5 days, followed by restimulation with the original concentration of peptide or P/I for 5 hours in the presence of BFA, fixed and analyzed for cytokine or transcription factor as indicated. (A) Cell number (top panel) and Ki67 expression (bottom panel) of resultant cells as a function of peptide concentration. (B) Percent IFN-γ, TNFα or double producers as a function of peptide concentration. (C) Cells restimulated with P/I and analyzed for percent IFN-γ, TNFα or double producers as a function of peptide concentration. n = 3, 3 independent experiments. (D) MFI of cytokine expressing cells as a function of peptide concentration. (E) Percent of T-bet, Eomesodermin or double expressers as function of peptide concentration. \*p \< 0.05, n = 3 for 3 independent experiments. All error bars indicate the value of +/−SEM.](srep07688-f1){#f1}

![Itk tunes the expression of Eomes and development of MPECS during infection.\
Naïve WT or Itk^−/−^ T cells were transferred separately into WT mice, which were infected with *L. monocytogenes*. Mice were bled on the indicated days and cells analyzed as indicated. (A) Cell number. (B) Bacterial numbers in liver determined from mice infected for day 2 or day 7, and. n = 4, 3 independent experiments, no bacteria detected. (C) Percent SLEC and MPEC. (D) Percent T-bet and Eomes. \*p \< 0.05, n = 3--8 mice, 3 independent experiments. (E) Flow cytometric analysis of the expression of CD127 (left panels) or Eomes (right panels) in representative mice. (F) Naïve WT or Itk^−/−^ T cells were stimulated with 20 μg/ml OVA plus antigen presenting cells over 5 days. Cells were analyzed for expression of IRF4 by flow cytometry. n = 3. (G) IRF4 expression was determined by flow cytometry in WT or Itk^−/−^ OTI/Rag^−/−^ T cells following transfer into WT mice and infection with *L. monocytogenes* for 5 days. n = 3--8 mice, 3 independent experiments. All error bars indicate the value of +/−SEM.](srep07688-f2){#f2}

![Itk regulates the production of effector cytokines during infection.\
Analysis of WT or Itk^−/−^ T cells for cytokine production during infection as indicated. (A) Percent and MFI of cytokine positive cells (IFN-γ, left panels), (TNFα, right panel). (B) Percent IFN-γ/TNFα double positive cells. \*p \< 0.05, n = 3--8 mice, 3 independent experiments. All error bars indicate the value of +/−SEM.](srep07688-f3){#f3}

![Itk signals are not required for CD8^+^ T cell memory responses.\
Naïve WT or Itk^−/−^ T cells were transferred into WT mice, which were infected with *LM-OVA*. After 30 days, mice were infected with 10× the initial dose of bacteria, and analyzed 3 days post-infection. (A) Percent IFN-γ, TNFα, and IFN-γ/TNFα double positive cells (left panel), as well as MFI IFN-γ or TNFα positive cells (right panel). (B) Cell number (left panel). \*p \< 0.05, n = 7 mice, 3 independent experiments. Fold difference in cell numbers between Itk^−/−^ and WT T cells (expressed as ratio Itk^−/−^:WT T cells) after the primary response (day 28, data from [Fig. 2A](#f2){ref-type="fig"}), or after the recall response (data from left panel). All error bars indicate the value of +/−SEM. n.s. = no statistically significant difference in fold expansion between Itk^−/−^ and WT T cells between the primary response and secondary response. (C) Naïve WT or Itk^−/−^ T cells were transferred into WT mice, which were infected with *LM-OVA*. After 30 days, memory donor CD8^+^ T cells were isolated, then transferred (40,000/mouse) into naïve mice, which were infected with 10× the initial dose of bacteria, and number of donor CD8^+^ T cells analyzed 3 days post-infection. All error bars indicate the value of +/−SEM. n = 4--5 mice. Experiment performed 1×.](srep07688-f4){#f4}
